Tokyo Tape
Sign in
← H.U. Group Holdings

Quarterly report · Q3

4544.TEDINET S100Q5GN
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥201.0bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥272.9bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥197.9bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥23.6bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥36.2bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥23.2bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥47.4bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥35.5bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥25.8bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥33.7bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥18.8bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥29.6bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥25.5bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥18.8bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥25.5bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥280.3bnat 2022-12-31Cons.Assets
Total assets¥286.6bnat 2022-03-31Cons.Assets
Total assets¥277.0bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥127.2bnat 2022-12-31Cons.Liabilities
Total liabilities¥146.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥153.2bnat 2022-12-31Cons.Net assets
Net assets / equity¥140.2bnat 2022-03-31Cons.Net assets
Net assets / equity¥133.6bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥30.5bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥46.5bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥30.5bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥46.5bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥46.2bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥43.0bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥19.2bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥55.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥38.4bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥24.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥30.9bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥19.2bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥10.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥21.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥16.1bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥330.262022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥56.842022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥519.552021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥447.682021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥105.452021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥330.222022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥519.422021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥447.552021-04-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio54.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio48.9%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio48.2%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥6.2bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥6.2bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥3.3bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥124.9bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥124.7bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥212m
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.7bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥61.6bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥55.6bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥5.9bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥23.4bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2022-04-01 → 2022-12-31¥20.7bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2022-04-01 → 2022-12-31¥20.6bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥15m
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2022-04-01 → 2022-12-31¥825m
—segment totalrevenue2022-04-01 → 2022-12-31¥207.1bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥201.0bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥6.2bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥26.9bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥7.2bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥7.2bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥775m
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥131.2bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥131.0bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥216m
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2021-04-01 → 2021-12-31¥17.7bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥52.1bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥45.2bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥7.0bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2021-04-01 → 2021-12-31¥17.8bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2021-04-01 → 2021-12-31¥21.8bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2021-04-01 → 2021-12-31¥21.7bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥15m
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2021-04-01 → 2021-12-31¥1.4bn
—segment totalrevenue2021-04-01 → 2021-12-31¥205.1bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥197.9bn
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥7.2bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥36.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 479
ItemContextValueUnit
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration-596000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration152000000JPY
Other comprehensive incomePrior1YTDDuration2176000000JPY
Other comprehensive incomeCurrentYTDDuration1319000000JPY
Comprehensive incomePrior1YTDDuration27657000000JPY
Comprehensive incomeCurrentYTDDuration20109000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration27695000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration20109000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-37000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration－JPY
Income before income taxesPrior1YTDDuration33716000000JPY
Income before income taxesCurrentYTDDuration25786000000JPY
Depreciation and amortization ope cfPrior1YTDDuration10335000000JPY
Depreciation and amortization ope cfCurrentYTDDuration14222000000JPY
Amortization of goodwill ope cfPrior1YTDDuration79000000JPY
Amortization of goodwill ope cfCurrentYTDDuration256000000JPY
Equity in earnings losses of affiliates ope cfPrior1YTDDuration1407000000JPY
Equity in earnings losses of affiliates ope cfCurrentYTDDuration1315000000JPY
Decrease increase in trade receivables and contract assets ope cfPrior1YTDDuration-2149000000JPY
Decrease increase in trade receivables and contract assets ope cfCurrentYTDDuration5153000000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-1730000000JPY
Decrease increase in inventories ope cfCurrentYTDDuration-1287000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration1063000000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration-921000000JPY
Increase decrease in provision for bonuses ope cfPrior1YTDDuration-2097000000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration-2951000000JPY
Gain on sales of non current assets ope cfPrior1YTDDuration-80000000JPY
Gain on sales of non current assets ope cfCurrentYTDDuration-2622000000JPY
Loss gain on step acquisitions ope cfPrior1YTDDuration－JPY
Loss gain on step acquisitions ope cfCurrentYTDDuration-758000000JPY
Increase decrease in accrued consumption taxes ope cfPrior1YTDDuration220000000JPY
Increase decrease in accrued consumption taxes ope cfCurrentYTDDuration-1760000000JPY
Increase decrease in other current liabilities ope cfPrior1YTDDuration1780000000JPY
Increase decrease in other current liabilities ope cfCurrentYTDDuration-3989000000JPY
Increase decrease in other noncurrent liabilities ope cfPrior1YTDDuration399000000JPY
Increase decrease in other noncurrent liabilities ope cfCurrentYTDDuration809000000JPY
Other net ope cfPrior1YTDDuration-1905000000JPY
Other net ope cfCurrentYTDDuration-340000000JPY
Subtotal ope cfPrior1YTDDuration41039000000JPY
Subtotal ope cfCurrentYTDDuration32912000000JPY
Income taxes paid ope cfPrior1YTDDuration-2404000000JPY
Income taxes paid ope cfCurrentYTDDuration-13617000000JPY
Other net ope cf subtotalPrior1YTDDuration-268000000JPY
Other net ope cf subtotalCurrentYTDDuration-110000000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration38366000000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration19185000000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration-14024000000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-10592000000JPY
Proceeds from sales of property plant and equipment inv cfPrior1YTDDuration305000000JPY
Proceeds from sales of property plant and equipment inv cfCurrentYTDDuration2677000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass